Imagenebio Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Imagenebio Inc 's ROA in the second quarter of 2026?
Imagenebio Inc recorded a cumulative net loss of $-55 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -35.11%.

However, within the Healthcare sector 466 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3747, from total ROA ranking in the first quarter of 2026 at 4330.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	55.56 %	1.9 %	503.37 %	5.61 %	-19.25 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-55	-52	-48	-48	-26
Return On Assets (TTM)	-35.11 %	-37.62 %	-34.49 %	-44.2 %	-24.6 %
IMA's Total Ranking	# 3747	# 4330	# 3955	# 3677	# 3661
Total Assets (TTM) in million	194	131	146	153	124
Seq. Total Assets Change	47.82 %	-10.28 %	-4.83 %	23.25 %	-3.17 %
Seq. Net Income Change	-	-	-	-	-

IMA's 5 Years Annual ROA >> Back to IMA Management Effectiveness >> Compare IMA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 54
Sector	# 467
Overall	# 3716

Return On Assets Statistics
High	Average	Low
-12.61 %	-30.99 %	-43.86 %
(Dec 31 2021)		(Sep 30 2025)

Financial Statements
Imagenebio Inc 's Assets	$ 194 million	IMA's Balance sheet
Imagenebio Inc 's Income	$ -10 million	Quarterly IMA's Income Statement
IMA's Income by Division		See IMA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	5.18 %	-26.19 %	12.43 %	-30.89 %	-
Total Assets in million	146	139	188	167	242
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-45	-49	-68	-69	-34
Annual Return On Assets	-31.07 %	-35.48 %	-36.26 %	-41.12 %	-14.1 %

IMA's 5 Years Annual ROA >> Back to IMA Management Effectiveness >> Compare IMA ROA to its Competitors

More Return On Assets Ratios
IMA's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMA's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMA's Competitors
Subscribers only: Roa for Imagenebio Inc 's Suppliers
Subscribers only: Return On Assets for IMA's Customers

You may also want to know
IMA's Roi	IMA's Inventory Turnover Ratio	IMA's Growth Rates	IMA's Dividend Comparisons
	IMA's Profitability Ratios	IMA's Asset Turnover Ratio	IMA's Dividend Growth
IMA's Roe	IMA's Valuation Ratios	IMA's Financial Strength Ratios	IMA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-10T13:46:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.